Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis B Virus Elevates Risk for Age-Related Macular Degeneration

Those with hepatitis B virus have a significantly elevated risk for developing any type of age-related macular degeneration (AMD), according to a new report. It’s possible that hepatitis B virus may even accelerate the progression of AMD.

Published
14 March 2019
From
MD Magazine
Dramatic rise in U.S. opioid deaths as epidemic spreads to eastern states

Long believed to be concentrated among Appalachian states and parts of the Midwest, Alexander's research shows that the crisis has spread. Eastern states have seen a sharp rise in opioid deaths – with Connecticut, Illinois, Indiana, Massachusetts, Maryland, Maine, New Hampshire and Ohio among the states with the highest rise in opioid-related deaths.

Published
13 March 2019
From
Medical Xpress
Pilot study finds HCV treatment safe in pregnancy

A small pilot study of hepatitis C treatment in pregnant women found that that the treatment was effective in achieving hepatitis C cure and identified no safety concerns associated with treatment, according to findings presented at CROI.

Published
11 March 2019
From
Healio
'Patient No. 1' from a Hep C heart transplant study shares his story

By the time three transplant physicians approached Tom Giangiulio Jr. about being the first patient in a new clinical trial to accept a heart from a Hepatitis C-positive donor, Giangiulio didn’t have much of a choice.

Published
08 March 2019
From
Cardiovascular Business
Hepatitis C Treatment Market to Exceed US$ 71.13 Bn by the end of 2024

The global hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a cumulative annual growth rate of 13.1% over the forecast period.

Published
04 March 2019
From
Honest Businessman
A new way to pay for innovative drugs, provide universal access and not break the bank

Louisiana, which has a severe hepatitis C problem, is on the cusp of proving to other states that drug companies can make the money they need, while every Medicaid recipient who needs a cure gets one. The state is now on a path to secure immediate treatment for all infected prisoners and people on Medicaid by buying a license from a drug company. It is a concept that can be applied to other ground breaking remedies.

Published
28 February 2019
From
The Conversation
India: National action plan for free treatment of hepatitis patients launched

National action plan for free treatment of hepatitis patients launched  The HinduEnvisages model treatment centres in all States in the first year.

Published
27 February 2019
From
The Hindu
Penn team eradicates Hepatitis C in patients after heart transplants from infected donors

Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American Journal of Transplantation.

Published
26 February 2019
From
Eurekalert Medicine & Health
Expert working group recommends bold action to eliminate hepatitis C in Scotland; now we need a national elimination strategy

A new report published by Health Protection Scotland sets out national recommendations for improvements to case finding and access to care which would accelerate Scotland’s efforts to eliminate hepatitis C. The Hepatitis C Trust calls on the Scottish Government to set out a clear timeline and process for developing and releasing a national elimination strategy for hepatitis C, in order to facilitate implementation of the recommendations contained in the recent Health Protection Scotland report.

Published
19 February 2019
From
Hepatitis C Trust
Trial launched to study HIV-to-HIV liver transplant outcomes

The new study will track the success of 80 liver transplants to HIV-positive people. Half of the livers will come from deceased HIV-positive donors and the other half will come from deceased HIV-negative donors.

Published
16 February 2019
From
UPI
← First12345...154Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.